[Report Description]
The growth of the live cell imaging market is attributed to the adoption of high-content screening techniques in drug discovery, the rising prevalence of chronic disease demanding higher and quicker diagnostic facilities, and government funding for cell-based research.
According to the World Health Organization, chronic diseases kill 41 million people each year, equivalent to 71% of all deaths globally. Increased demand for healthcare systems, due to the prevalence of chronic diseases, has become a major concern. Also, increasing age and lifestyle-related chronic diseases are driving the healthcare demand and spending. In developing markets, cancer and heart diseases are becoming the main causes of death, owing to urbanization, sedentary lifestyles, changing diets, rising obesity levels, and widespread availability of tobacco products. Due to the increasing prevalence of chronic diseases, there is a high demand for medical devices that enable early detection and quick diagnosis, which could prove to be particularly impactful. Furthermore, government initiatives are also supporting cell-based research, which boosts this studied market.
Key Market Trends
The Equipment Segment is Expected to Grow Fastest During the Forecast Period
The equipment segment includes microscopes, cell analyzers, image capturing systems, and standalone systems. Recent technological advancements in microscopes have augmented the growth of the market. For instance, an inverted research-grade microscope has supported imaging of adherent cells and organelles and yields results for tissue sections of less than 5 um thickness. The overall industry trend is shifting toward automation, integration of systems, and maximizing data generation from microscopes. According to the World Health Organization, 15 million people die from a chronic disease between the ages of 30 and 69 years every year. Cardiovascular diseases account for most NCD deaths, or 17.9 million people annually, followed by cancers. Thus, the increasing burden of chronic diseases and the need for scientists to study the nature and function of cells are boosting the growth of the segment.
The North America Region Holds the Largest Market Share and is Expected to Follow the Same Trend over the Forecast Period
North America dominated the market. The major share is attributed to the presence of a larger patient pool and increasing geriatric population. The generous investment and funding available for research in live-cell imaging are the key drivers in this region. In the North American region, the United States holds the largest market share due to factors, such as an increasing number of chronic diseases, along with a growing number of R&D programs in the country. According to the latest estimates from the Centers for Disease Control and Prevention 2018, about 37,832 people received an HIV diagnosis in the United States. As per the statistics, the large patient pool and high disposable income help the government and research organizations to propel the market growth in this region.
Competitive Landscape
The live cell imaging market consists of several major players, including Becton, Dickinson and Company, Carl Zeiss, and Leica Microsystems, among many others. The companies are implementing certain strategic initiatives, such as mergers, new product launches, acquisitions, and partnerships that help them in strengthening their market positions. For instance, in March 2018, Nikon Corporation released a new product new N-SIM S Super-Resolution Microscope, which enables super-solution imaging of live cells at 10 times greater than the speed of conventional structured illumination microscopy (SIM).
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Adoption of High-content Screening Techniques in Drug Discovery
4.2.2 Rising Prevalence of Chronic Disease Demanding Higher and Quicker Diagnostic Facilities
4.2.3 Government Funding for Cell-based Research
4.3 Market Restraints
4.3.1 High Cost of High-content Screening Systems
4.3.2 Shortage of Skilled Professionals
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Equipment
5.1.1.1 Standalone Systems
5.1.1.2 Microscopes
5.1.1.3 Cell Analyzers
5.1.1.4 Image Capturing Devices
5.1.2 Consumables
5.1.2.1 Reagents and Kits
5.1.2.2 Other Consumables
5.1.3 Software and Services
5.2 By Application
5.2.1 Cell Biology
5.2.2 Developmental Biology
5.2.3 Stem Cell Biology
5.2.4 Drug Discovery
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Becton, Dickinson and Company
6.1.2 Carl Zeiss AG
6.1.3 GE Healthcare
6.1.4 Leica Microsystems
6.1.5 Olympus Corporation
6.1.6 Molecular Devices LCC
6.1.7 Nikon Corporation
6.1.8 PerkinElmer Inc.
6.1.9 Sigma-Aldrich Corporation
6.1.10 Thermo Fisher Scientific Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
